Mechanism and therapeutic reversal of immune suppression in cancer

被引：34
作者：
Herber, Donna L. [1 ]
Nagaraj, Srinivas [1 ]
Djeu, Julie Y. [1 ]
Gabrilovich, Dmitry I. [1 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
来源：
CANCER RESEARCH | 2007年 / 67卷 / 11期
关键词：
D O I：
10.1158/0008-5472.CAN-07-0897
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：5067 / 5069
页数：3
相关论文
共 14 条
[1]   Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer [J].
Antonia, SJ ;
Mirza, N ;
Fricke, I ;
Chiappori, A ;
Thompson, P ;
Williams, N ;
Bepler, G ;
Simon, G ;
Janssen, W ;
Lee, JH ;
Menander, K ;
Chada, S ;
Gabrilovich, DI .
CLINICAL CANCER RESEARCH, 2006, 12 (03) :878-887
[2]   Cancer vaccines: Between the idea and the reality [J].
Finn, OJ .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (08) :630-641
[3]   Mechanisms and functional significance of tumour-induced dendritic-cell defects [J].
Gabrilovich, D .
NATURE REVIEWS IMMUNOLOGY, 2004, 4 (12) :941-952
[4]   The role of the transcription factor Foxp3 in the development of regulatory T cells [J].
Kim, Jeong M. ;
Rudensky, Alexander .
IMMUNOLOGICAL REVIEWS, 2006, 212 :86-98
[5]   Checkpoint blockade in cancer immunotherapy [J].
Korman, AJ ;
Peggs, KS ;
Allison, JP .
ADVANCES IN IMMUNOLOGY, VOL 90: CANCER IMMUNOTHERAPY, 2006, 90 :297-339
[6]   Immunotherapy for pancreatic cancer - Science driving clinical progress [J].
Laheru, D ;
Jaffee, EM .
NATURE REVIEWS CANCER, 2005, 5 (06) :459-467
[7]   Indoleamine 2,3-dioxygenase, tumor-induced tolerance and counter-regulation [J].
Munn, DH .
CURRENT OPINION IN IMMUNOLOGY, 2006, 18 (02) :220-225
[8]   T cell dysfunction in cancer:: Role of myeloid cells and tumor cells regulating amino acid availability and oxidative stress [J].
Rodríguez, PC ;
Ochoa, AC .
SEMINARS IN CANCER BIOLOGY, 2006, 16 (01) :66-72
[9]   Myeloid suppressor cells in cancer: Recruitment, phenotype, properties, and mechanisms of immune suppression [J].
Serafini, P ;
Borrello, I ;
Bronte, V .
SEMINARS IN CANCER BIOLOGY, 2006, 16 (01) :53-65
[10]   Tumor immunity: a balancing act between T cell activation, macrophage activation and tumor-induced immune suppression [J].
Sinha, P ;
Clements, VK ;
Miller, S ;
Ostrand-Rosenberg, S .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2005, 54 (11) :1137-1142
12